The regulatory role of the n-6/n-3 ratio in intestinal barrier function and glucose and lipid metabolism disorders

preprint OA: closed CC-BY-4.0
📄 Open PDF Full text JSON View at publisher
AI-generated deep summary by claude@2026-07, 2026-07-04 · read from full text

This preprint studied how dietary n-6/n-3 polyunsaturated fatty acid ratios affect intestinal barrier function and glucose/lipid metabolism in a high-fat diet mouse model of diabetes, comparing 20:1, 10:1, and 4:1 over 12 weeks. Lowering the ratio to 4:1 increased villus height and tight-junction protein levels by about 50%, reduced plasma lipopolysaccharide by 42%, and decreased HOMA-IR by 32%, alongside microbiota shifts toward higher Bifidobacterium and Bacteroides. The authors report these changes as indicating improved barrier integrity, lower endotoxin levels, and better insulin sensitivity, while noting the work is a preprint that has not been peer reviewed. This paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Abstract An unbalanced intake of n-6 and n-3 polyunsaturated fatty acids (PUFAs) can damage the gut barrier and disturb metabolism. This study used a high-fat diet mouse model of diabetes to examine the effects of different n-6/n-3 ratios (20:1, 10:1, and 4:1). Mice were fed the test diets for 12 weeks. When the ratio was reduced to 4:1, villus height and tight-junction protein levels increased by about 50%. Plasma lipopolysaccharide (LPS) dropped by 42%, and the HOMA-IR index decreased by 32%. The gut microbiota also changed, showing more Bifidobacterium and Bacteroides in the 4:1 group. These results indicate that a lower n-6/n-3 ratio supports the intestinal barrier, lowers endotoxin levels, and improves insulin sensitivity. The study suggests that keeping an n-6/n-3 ratio near 4:1 may help control inflammation and reduce metabolic problems linked to diabetes.
Full text 10,306 characters · extracted from preprint-html · click to expand
The regulatory role of the n-6/n-3 ratio in intestinal barrier function and glucose and lipid metabolism disorders | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article The regulatory role of the n-6/n-3 ratio in intestinal barrier function and glucose and lipid metabolism disorders Luca Moretti, Anna Kovács, Erik M. Lindberg This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-7997486/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract An unbalanced intake of n-6 and n-3 polyunsaturated fatty acids (PUFAs) can damage the gut barrier and disturb metabolism. This study used a high-fat diet mouse model of diabetes to examine the effects of different n-6/n-3 ratios (20:1, 10:1, and 4:1). Mice were fed the test diets for 12 weeks. When the ratio was reduced to 4:1, villus height and tight-junction protein levels increased by about 50%. Plasma lipopolysaccharide (LPS) dropped by 42%, and the HOMA-IR index decreased by 32%. The gut microbiota also changed, showing more Bifidobacterium and Bacteroides in the 4:1 group. These results indicate that a lower n-6/n-3 ratio supports the intestinal barrier, lowers endotoxin levels, and improves insulin sensitivity. The study suggests that keeping an n-6/n-3 ratio near 4:1 may help control inflammation and reduce metabolic problems linked to diabetes. General Cell Biology & Physiology Applied Biochemistry n-6/n-3 ratio gut barrier lipopolysaccharide tight-junction proteins insulin resistance gut microbiota diabetes Full Text Additional Declarations The authors declare no competing interests. Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-7997486","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":538001652,"identity":"6cec8dda-7042-4770-9f47-4dc3f75517be","order_by":0,"name":"Luca Moretti","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAA1ElEQVRIiWNgGAWjYJCCgx8MJHjsjzcAmQYWxGk5LFFgIcNw5gBIiwSR1vB8qLBhuJEAYhKhxeBG8sEDEkCHMc58fnXDjwIJBv727gQCWtISDhQAtTBL55Td7AE6TOLM2Q14tZjdzjEA28ImnZN2gweoxUAil5CW/A8HgCp5eCTPpN38Q5yWHAawFgkJ9mO3ibLF/v4zg8Mghxnw5LDdlgHpJeQXyZ7Djz9++FNnb8B+/NnNN39s5Pjbe/FrQQI8BmCSWOUgwP6AFNWjYBSMglEwggAAZcxGvUe08xYAAAAASUVORK5CYII=","orcid":"","institution":"Department of Clinical Medicine, Lund University, Lund SE-221 00, Sweden","correspondingAuthor":true,"prefix":"","firstName":"Luca","middleName":"","lastName":"Moretti","suffix":""},{"id":538001653,"identity":"14eac279-31fe-4b6e-b787-e68e5a1272be","order_by":1,"name":"Anna Kovács","email":"","orcid":"","institution":"Department of Clinical Medicine, Lund University, Lund SE-221 00, Sweden","correspondingAuthor":false,"prefix":"","firstName":"Anna","middleName":"","lastName":"Kovács","suffix":""},{"id":538001654,"identity":"48f89005-ea9c-4b08-95a3-73435932f2f8","order_by":2,"name":"Erik M. Lindberg","email":"","orcid":"","institution":"Department of Clinical Medicine, Lund University, Lund SE-221 00, Sweden","correspondingAuthor":false,"prefix":"","firstName":"Erik","middleName":"M.","lastName":"Lindberg","suffix":""}],"badges":[],"createdAt":"2025-10-31 10:37:56","currentVersionCode":1,"declarations":{"humanSubjects":false,"vertebrateSubjects":false,"conflictsOfInterestStatement":false,"humanSubjectEthicalGuidelines":false,"humanSubjectConsent":false,"humanSubjectClinicalTrial":false,"humanSubjectCaseReport":false,"vertebrateSubjectEthicalGuidelines":false},"doi":"10.21203/rs.3.rs-7997486/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-7997486/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":94988890,"identity":"d4237e40-9494-47d5-84de-21b84c59f091","added_by":"auto","created_at":"2025-11-03 07:11:17","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":731039,"visible":true,"origin":"","legend":"","description":"","filename":"10.2805yawenTheregulatoryroleofthen6n3ratioinintestinalbarrierfunctionandglucoseandlipidmetabolismdisorders.pdf","url":"https://assets-eu.researchsquare.com/files/rs-7997486/v1_covered_a32c0a4a-c1aa-48b0-b01b-6b4b8ddd016e.pdf"}],"financialInterests":"The authors declare no competing interests.","formattedTitle":"\u003cp\u003e\u003cstrong\u003eThe regulatory role of the n-6/n-3 ratio in intestinal barrier function and glucose and lipid metabolism disorders\u003c/strong\u003e\u003c/p\u003e","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":true,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"n-6/n-3 ratio, gut barrier, lipopolysaccharide, tight-junction proteins, insulin resistance, gut microbiota, diabetes","lastPublishedDoi":"10.21203/rs.3.rs-7997486/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-7997486/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003eAn unbalanced intake of n-6 and n-3 polyunsaturated fatty acids (PUFAs) can damage the gut barrier and disturb metabolism. This study used a high-fat diet mouse model of diabetes to examine the effects of different n-6/n-3 ratios (20:1, 10:1, and 4:1). Mice were fed the test diets for 12 weeks. When the ratio was reduced to 4:1, villus height and tight-junction protein levels increased by about 50%. Plasma lipopolysaccharide (LPS) dropped by 42%, and the HOMA-IR index decreased by 32%. The gut microbiota also changed, showing more \u003cem\u003eBifidobacterium\u003c/em\u003e\u0026nbsp;and \u003cem\u003eBacteroides\u003c/em\u003e\u0026nbsp;in the 4:1 group. These results indicate that a lower n-6/n-3 ratio supports the intestinal barrier, lowers endotoxin levels, and improves insulin sensitivity. The study suggests that keeping an n-6/n-3 ratio near 4:1 may help control inflammation and reduce metabolic problems linked to diabetes.\u003c/p\u003e","manuscriptTitle":"The regulatory role of the n-6/n-3 ratio in intestinal barrier function and glucose and lipid metabolism disorders","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2025-11-03 02:42:26","doi":"10.21203/rs.3.rs-7997486/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"1de49bdd-6527-4151-bae4-395247035b62","owner":[],"postedDate":"November 3rd, 2025","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[{"id":57219148,"name":"General Cell Biology \u0026 Physiology"},{"id":57219149,"name":"Applied Biochemistry"}],"tags":[],"updatedAt":"2025-11-03T02:42:26+00:00","versionOfRecord":[],"versionCreatedAt":"2025-11-03 02:42:26","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-7997486","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-7997486","identity":"rs-7997486","version":["v1"]},"buildId":"8U1c8b4HqxoKbykW_rLl7","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-30T02:00:01.510937+00:00
License: CC-BY-4.0